In its efforts to spread awareness on the deadly diseases, Hepatitis B and C among majority of Africans, Gilead Sciences, a research-based biopharmaceutical firm, will lead a health campaign to the ongoing African Cup of Nations (AFCON). Through a partnership with the Africa’s biggest football to
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp